Evotec acquires translational projects firm Bionamics
This article was originally published in Scrip
German drug discovery services firm Evotec has acquired Bionamics, a German asset management company, for an undisclosed amount. Bionamics is focused on translating academic innovations into useful projects for pharma and biotech companies. This is a good fit with Evotec's EVT Innovate, an initiative under which the company develops early stage projects until they are ready for licensing by pharma companies.